Biggest News Aggregation in the World
📰 Exploratory Analysis News

Page 2 - Exploratory Analysis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Exploratory Analysis. Real-time updates on events, politics, business and more.

Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA (pembrolizumab)

10.05.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that data for six approved medicines and pipeline candidates in more than 25 types of cancer will be presented at the 2022 American Society of Clinical Oncology ...
United States Neoadjuvant Pembrolizumab Pembrolizumab Pembro Pembrolizumab Monotherapy Statement Of Merck Co Inc Merck Co Inc

Takeda Pharmaceutical Company Limited: Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY (Maribavir) Had Reductions in Hospitalization Rates and Length of Hospital Stay

Data Include Exploratory Analysis Showing LIVTENCITY Treated Patients With Post-Transplant Cytomegalovirus (CMV) Infections/Disease Had Reductions in Hospitalizations (34.8%; p=0.021) and Length
United States Salt Lake City Barbara Alexander Jun Saito Clin Virol Erin Marie Beals

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases

Research to be presented on Orencia, deucravacitinib and pipeline assets highlights breadth of data and focus on transforming treatment paradigms for people living with rheumatic diseases Bristol Myers Squibb today announced data from 29 company-sponsored presentations across Orencia, deucravacitinib and pipeline assets will be presented at the American College of Rheumatology Convergence 2021, taking place ...
Hermine Brunner Manoj Chiney Kristin Wipfler Paul Emery Uzma Nakshbandi Laure Gossec

Stocks plunge amid fears of second wave

Stocks plunge amid fears of second wave Premium Share Via Read Full Story Fears of a second wave of covid-19 infections and a likely surge in inflation from higher crude prices dragged Indian stocks by the most in two months on Monday, in tandem with falling equities and rising bond yields worldwide. The BSE Sensex fell 1,145.44 points or 2.25% to close at 49,744.32, while the broader Nifty index lost 306.05 points or 2.04% to close at 14,675.70. Indian indices are now 5% below their record hig...
Jammu And Kashmir Madhya Pradesh New Delhi Tamil Nadu Elon Musk Harsh Mahajan

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science